SP-MHCI-0558-2

M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 166-174, SMAGSSAMI

US$169.00

In stock

Description

About M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 166-174, SMAGSSAMI

The M. tuberculosis (strain ATCC 25177 / H37Ra) Diacylglycerol acyltransferase/mycolyltransferase Ag85A Peptide (IEDB: 59627) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Diacylglycerol acyltransferase/mycolyltransferase Peptide, H-SMAGSSAMI-OH (Uniprot: A5U3Q3 aa: 166-174) from JPT is produced under strict quality control and quality management.

M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 166-174, SMAGSSAMI - Specifications

  • Peptide sequence: H-SMAGSSAMI-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Tuberculosis
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 166-174, SMAGSSAMI

References:
Read References with JPT’s Antigen Peptides
M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 166-174, SMAGSSAMI has been described in:
Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis., Genes Immun, 2007 (PMID: 17429413)
Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans., J Immunol, 2000 (PMID: 11086086)
Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation., Mol Cell Proteomics, 2015 (PMID: 25576301)

Documentation

Documentation for M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 166-174, SMAGSSAMI

Properties

Properties of M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 166-174, SMAGSSAMI

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Tuberculosis
Layout: Freeze-dried in glass vial
Organism: M. tuberculosis
Protein Name: Diacylglycerol acyltransferase/mycolyltransferase
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 166-174, SMAGSSAMI

Information Values
Sequence: H-SMAGSSAMI-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote